Baird Financial Group’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.37M Sell
26,198
-1,371
-5% -$116K ﹤0.01% 1041
2026
Q1
$2.3M Sell
27,569
-10,662
-28% -$875K ﹤0.01% 1001
2025
Q4
$3.5M Sell
38,231
-2,942
-7% -$282K 0.01% 848
2025
Q3
$3.9M Sell
41,173
-4,071
-9% -$383K 0.01% 830
2025
Q2
$4.74M Buy
45,244
+35,646
+371% +$3.38M 0.01% 738
2025
Q1
$848K Buy
+9,598
New +$984K ﹤0.01% 1233

Other funds holding HQY

Baird Financial Group's HQY Position: Q2 2026 in Review

Baird Financial Group reduced its HealthEquity (HQY) stake by 5% in Q2 2026, selling an estimated $116K and leaving 26,198 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1041.

Baird Financial Group first reported a position in HQY in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.74M in Q2 2025. 500 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Baird Financial Group held 26,198 shares of HealthEquity worth $2.37M as of Q2 2026.
  • Baird Financial Group sold 1,371 HealthEquity shares in Q2 2026, an estimated $116K.
  • HealthEquity made up ﹤0.01% of Baird Financial Group's portfolio in Q2 2026, its #1041 holding.
  • Baird Financial Group first reported a position in HealthEquity in Q1 2025 and has held it in 6 quarters since.
  • Baird Financial Group's HealthEquity position peaked at $4.74M in Q2 2025.
  • 500 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.